Header image

Impact Factor Journals
Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma.
Future Oncology.
2020,
17(3),
241-254,
ISSN: 1479-6694,
PMID: 33016119,
Safety testing of adult novelties using in vitro methods.
Regulatory Toxicology and Pharmacology.
2020,
117,
104780,
ISSN: 0273-2300,
PMID: 32898621,
CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells.
Cell Death & Disease.
2020,
11(9),
754,
ISSN: 2041-4889,
PMID: 32898621,
CDKN1A Gene Expression in Two Multiple Myeloma Cell Lines With Different P53 Functionality.
Anticancer Research.
2020,
40(9),
4979-4987,
ISSN: 0250-7005,
PMID: 32878786,
Head-To-Head Comparison of Biological Behavior of Biocompatible Polymers Poly(Ethylene Oxide), Poly(2-Ethyl-2-Oxazoline) and Poly[N-(2-Hydroxypropyl)Methacrylamide] as Coating Materials for Hydroxyapatite Nanoparticles in Animal Solid Tumor Model.
Nanomaterials.
2020,
10(9),
E1690,
ISSN: 2079-4991,
PMID: 32867391,
PDF.
Severe linezolid-induced lactic acidosis in a child with acute lymphoblastic leukemia: A case report.
Journal of Infection and Chemotherapy.
2020,
26(12),
1316-1318,
ISSN: 1341-321X,
PMID: 32859497,
Effects of zinc porphyrin and zinc phthalocyanine derivatives in photodynamic anticancer therapy under different partial pressures of oxygen in vitro.
Investigational New Drugs.
2020,
39(1),
89-97,
ISSN: 0167-6997,
PMID: 32833137,
Comparison of bypass and non-bypass surgical treatments for internal carotid artery blood blister-like aneurysms: a meta-analysis of efficacy, safety and outcomes.
World Neurosurgery.
2020,
144,
283-292,
ISSN: 1878-8750,
PMID: 32829023,